System1 Biosciences Inc, a San Francisco-based neurotherapeutics company, has closed $25 million in Series A financing. CRV and Pfizer Ventures led the round with participation from Alexandria Venture Investments, Dolby Family Ventures, Longevity Fund, Riot Ventures, Kinled Holding, Wilmot Ventures, Webb Investment Network, Liquid 2 Ventures and Boom Capital.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: